NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL

中枢心血管控制的神经机制

基本信息

  • 批准号:
    2771230
  • 负责人:
  • 金额:
    $ 29.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-09-01 至 2002-08-31
  • 项目状态:
    已结题

项目摘要

Impressive progress has been made in defining and understanding supraspinal pathways with projections to spinal sympathetic preganglionic neurons (SPNs). In contrast, there has been little progress in characterizing another fundamental set of central nervous system pathways involved in the direct regulation of the sympathetic outflow, and therefore in the control of cardiovascular function. Almost nothing is known about putative neurotransmitters released by, or the locations of the cells of origin which give rise to, intraspinal circuits with monosynaptic connections to sympathetic preganglionic neurons. The present application focuses efforts in this direction and is particularly concerned with the identification of inhibitory pathways that are likely to be critical for the normal regulation of cardiovascular function and which may be compromised in at least one example of chronic, sympathetic hyperactivity. Using (1) pre- and postembedding immunoperoxidase, immunofluorescence, and immunogold immunocytochemical procedures; and (2) trans-synaptic and transneuronal labeling methods, the following light and electron microscopic projects have been proposed. Specific Aim 1 would test the hypothesis that glycine is an inhibitory neurotransmitter contained in terminals contacting sympathetic preganglionic neurons. The projects would determine: (1) the intracellular, somadendritic localization of glycine receptor-like immunoreactivity (GlyR-LIR, 93 kd subunit) within retrogradely labeled SPNs in four autonomic nuclei in thoracic spinal cord (Ilp, Ilf, IC, and CA); (2) whether terminal boutons opposite postsynaptic GlyR-LIR exhibit a homogeneous morphology; and (3) if boutons containing gamma-aminobutyric acid-like immunoreactivity (GABA-LIR) are opposite postsynaptic GlyR-LIR within SPNs. Specific Aim 2 would test the hypothesis that spinal' interneurons in laminae V and VII of thoracic spinal cord give rise to principal or collateral axon projections to SPNs. The studies would determine: (1) the segmental and intersegmental (propriospinal) distributions of spinal interneurons projecting to SPNs that have been retrogradely labeled with one of two transneuronally transported tracer substances: wheat germ agglutinin (WGA) or the atoxic binding fragment of tetanus toxin, Fragment C (TTC); and (2) whether the laminar and segmental distributions of WGA- or TTC-labeled spinal interneurons shift or remain constant when populations of SPNs with different postsynaptic targets are retrogradely labeled. Specific Aim 3 would test the hypothesis that transneuronally WGA- or TTC-labeled spinal-SPN pathways originating in laminae V and VII of thoracic spinal cord synthesize and release the inhibitory neurotransmitters glycine or GABA, and/or the excitatory neurotransmitter/ neuromodulator substance P(SP): do WGA- or TTC-labeled interneurons contain GABA-, glycine-, or SP-LIR? Specific Aim 4 would test the hypothesis that cardiovascular hyperactivity manifest in tetanus is a consequence of intoxication of inhibitory synapses contacting SPNs. The experiments would establish whether trans-synaptically TTC-labeled terminal boutons on SPNs in Ilf, Ilp, IC and CA: (1) contain GABA-LIR; and/or (2) are opposite postsynaptic GlyR-LIR. All experiments would be performed in rats.
在定义和理解方面取得了令人印象深刻的进展 脊髓上通路与脊髓交感节前神经的投射 神经元(SPNs)。 相比之下, 表征了另一组基本的中枢神经系统通路 参与交感神经流出的直接调节, 从而控制心血管功能。 几乎毫无所 已知推定的神经递质释放,或位置 产生脊髓内回路的起源细胞, 交感节前神经元的单突触连接。 的 本申请将努力集中在这个方向上, 与识别抑制途径有关, 对心血管功能的正常调节至关重要, 这可能在至少一个慢性、交感神经性 多动症。 使用(1)植入前和植入后免疫过氧化物酶, 免疫荧光和免疫金免疫细胞化学方法;和(2) 跨突触和跨神经元标记方法,以下光 和电子显微镜项目已经被提出。 具体目标1 将检验甘氨酸是一种抑制性神经递质的假设 包含在接触交感节前神经元的终末中。 的 项目将确定:(1)细胞内,体细胞 甘氨酸受体样免疫反应性(GlyR-LIR,93 kd)的定位 亚单位)内逆行标记的SPNs在四个自主神经核, 胸脊髓(Ilp、Ilf、IC和CA);(2)终末终扣是否 相反的突触后GlyR-LIR表现出均匀的形态;和(3) 如果含有γ-氨基丁酸样免疫反应性的终扣 (GABA-LIR)与SPN内的突触后GlyR-LIR相反。 具体目标 2将检验假设,脊髓'中间神经元在板V和 胸段脊髓的第VII神经元产生主轴突或侧支轴突 对SPN的预测。 这些研究将确定:(1)分段和 脊髓中间神经元的节段间(脊髓本体)分布 投射到已经被逆行标记为两个之一的SPN 经神经元转运的示踪物质:麦胚凝集素 (WGA)或破伤风毒素的无毒结合片段,片段C(TTC); 以及(2)WGA-或WGA-的层流和节段分布是否 TTC标记的脊髓中间神经元移位或保持不变, 对具有不同突触后靶点的SPNs进行了逆行标记。 具体目标3将检验跨神经元WGA-或 TTC标记的脊髓-SPN通路起源于脊髓的V层和VII层, 胸脊髓合成和释放抑制性 神经递质甘氨酸或GABA,和/或兴奋性 神经递质/神经调质P物质(SP):WGA或TTC标记 interneurons含有GABA-,甘氨酸-,或SP-LIR?具体目标4 验证心血管活动过度表现为破伤风的假设 是接触SPN的抑制性突触中毒的结果。 这些实验将确定跨突触TTC标记的 Ilf、Ilp、IC和CA的SPN终末结:(1)含有GABA-LIR; 和/或(2)与突触后GlyR-LIR相对。 所有的实验都是 在大鼠中进行。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN B CABOT其他文献

JOHN B CABOT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN B CABOT', 18)}}的其他基金

NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    2215713
  • 财政年份:
    1992
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    2215714
  • 财政年份:
    1992
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    3485810
  • 财政年份:
    1992
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    6056162
  • 财政年份:
    1992
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    2028047
  • 财政年份:
    1992
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    3485809
  • 财政年份:
    1992
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    6183564
  • 财政年份:
    1992
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    2028046
  • 财政年份:
    1992
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    3337516
  • 财政年份:
    1987
  • 资助金额:
    $ 29.94万
  • 项目类别:
NEURAL MECHANISMS OF CENTRAL CARDIOVASCULAR CONTROL
中枢心血管控制的神经机制
  • 批准号:
    3337517
  • 财政年份:
    1987
  • 资助金额:
    $ 29.94万
  • 项目类别:

相似海外基金

An atypical microtubule generation mechanism for neurons drives dendrite and axon development and regeneration
神经元的非典型微管生成机制驱动树突和轴突的发育和再生
  • 批准号:
    23K21316
  • 财政年份:
    2024
  • 资助金额:
    $ 29.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Characterizing Wnt Signaling Pathways in Axon Guidance
轴突引导中 Wnt 信号通路的特征
  • 批准号:
    10815443
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
Does phosphorylation regulation of the axon initial segment cytoskeleton improve behavioral abnormalities in ADHD-like animal models?
轴突起始段细胞骨架的磷酸化调节是否可以改善 ADHD 样动物模型的行为异常?
  • 批准号:
    23KJ1485
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Loss-of-function variants of the axon death protein SARM1 and protection from human neurodegenerative disease
轴突死亡蛋白 SARM1 的功能丧失变体和对人类神经退行性疾病的保护
  • 批准号:
    2891744
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
    Studentship
Collaborative Research: Evolution of ligand-dependent Robo receptor activation mechanisms for axon guidance
合作研究:用于轴突引导的配体依赖性 Robo 受体激活机制的进化
  • 批准号:
    2247939
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
    Standard Grant
Understanding the degeneration of axon and nerve terminals in Alzheimer's disease and related dementia brain
了解阿尔茨海默病和相关痴呆大脑中轴突和神经末梢的变性
  • 批准号:
    10661457
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
Unlocking BIN1 function in oligodendrocytes and support of axon integrity
解锁少突胶质细胞中的 BIN1 功能并支持轴突完整性
  • 批准号:
    10901005
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
The role of RNA methylation in cytoskeleton regulation during axon development
RNA甲基化在轴突发育过程中细胞骨架调节中的作用
  • 批准号:
    22KF0399
  • 财政年份:
    2023
  • 资助金额:
    $ 29.94万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了